Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 34-38

  Isonishi, S ^a   Ohkawa, K ^a   Tanaka, T ^a   Howell, S B ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug sensitivity; Platinum agents; Protein kinase C

Indexed keywords

CADMIUM CHLORIDE; CARBOPLATIN; CISPLATIN; ISOENZYME; MIBOPLATIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLATINUM DERIVATIVE; PROTEIN KINASE C;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SENSITIZATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0033988448     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0873     Document Type: Article

References (32)

1. Andrews PA and Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43
2. Andrews PA, Murphy MP and Howell SB (1985) Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res 45: 62511-6253
3. Balboa MA, Firestein BL, Godson C, Dell KS and Insel PA (1944) Protein kinase C alpha mediates phospholipase D activation by nucleotidcs and phorbol ester in Madin-Darby canine kidney cells. Stimulation of phospholipase D is independent of activation of polyphosphoinositide-specific phospholipase C and phospholipase A2. J Biol Chem 269: 10511-10516
4. Basu A, Teicher BA and Lazo JS (1990) Involvement of protein kinase C in phorbor ester-induced sensitization of Hela cells to cis-diamminedichloroplatinum(H). J Biol Chem 265: 8451-8457
5. WAF1/CIP1, Rb, and c-myc signaling in phorbol-resistant cancer cells. Cancer Res 57: 320-325
6. Brach MA, Herrmann F and Kufe DW (1992) Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells. Blood 79: 728-734
7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein using the principal of protein-dye binding. Anal Biochem 72: 248-254
8. Bruder JT, Heidecker G and Rupp UR (1992) Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes and Der 6: 545-556
9. Chambers TC, McAvoy EM, Jacobs JW and Eilon G (1990) Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 265: 7679-7687
10. Chmura SJ, Nodzenski E, Weichselbaum II, RR and Quintans J (1966) Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinasel. Cancer Res 56: 2711-2714
11. Craven PA and DeRubertis D (1988) Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation by unsatulated fatty acids. Gastroenterology 95: 676-685
12. Disaida PJ, Sinkovics JG, Kutledge FN and Smith JP (1972) Cell-mediated immunity to human malignant cells. Am J Obstet Gynecol 114: 979-989
13. Finc RL, Patel J and Chabner BA (1988) Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 85: 582-586
14. Fung H, Quinlan TR, Janssen YMW, Timblin CR, Marsh JP, Heintz NH, Taatjes DJ, Vacek P, Jaken S and Mossmanll BT (1997) Inhibition of protein kinase C prevents asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells. Cancer Res 57: 3101-3105
15. Gately DP and Howell SB (1993) Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67: 1171-1176
16. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC and Anderson ME (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci 89: 3070-3074
17. Hsu SL, Chou YH, Yin SC and Liu JY (1998) Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hcp3B cells. Biochem J 33: 57-64
18. Isonishi S, Andrews PA and Howell SB (1990) Increased sensitivity to cisdiamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate. J Biol Chem 265: 3623-3627
19. Isonishi S, Hom DK, Eastman A and Howell SB (1994a) Enhancement of sensitivity to platinum(II)-containing drugs by 12-O-tetradecanoylphorbol-13-acetate in a human ovarian carcinoma cell line. Br J Cancer 69: 217-221
20. Isonishi S, Ochiai K, Yasuda M, Ohkawa K and Terashima Y (1994b) Mechanism-related circumvention of cisplatin resistance in human ovarian carcinoma cells by (-)-(R)-2-aminomethylpyrrolidine ( 1, l-cyclobutanedicarboxylatojplatinum(II) monohydrate and modulation of its sensitivity by 12-O-tetradecanoylphorbol-13-acetate. Int J Oncol 5: 1309-1314
21. Kelly SL, Basu A, Teicher BA, Hacker MP, Hamer DH and Lzo JS (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science (Washington DC), 241: 1813-1815
22. Kolch W, Heldecker G, Kochs G, Hummel R, Vahida H, Mischak H, Finkenzeller G, Marmé D and Rapp UR (1993) Protein kinase Cα activates raf-1 by direct phosphorylation. Nature 364: 249-252
23. Kondo Y, Woo ES, Michalska AE, Andy Choo KH and Lazo J (1995) Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res 55: 2021-2023
24. Loehrer PJ and Einhorn LH (1984) Cisplatin. Ann Inter Med 100: 704-713
25. McCaffrey R, Ran W, Camisi J and Rosner MR (1987) Two independent growth factor-generated signals regulate c-fos and c-mye mRNA levels in Swiss 3T3 cells. J Biol Chem 262: 1442-1445
26. Niedel JE, Kuhn LJ and Vandenbark GR (1983) Phorbol diester receptor copurities with protein kinase C. Proc Natl Acad Sci USA 80: 36-40
27. Ozols RF and Young RC (1984) Chemotherapy of ovarian cancer. Semin Oncol 11: 251 -263
28. Rahmsdorf HJ and Herrlich P (1990) Regulation of gene expression by tumor promotors. Pharmacol Ther 48: 157-188
29. Rapp UR (1991 ) Role of raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 6: 495-500
30. Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW and Potter DW (1980) High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 106: 55-62
31. Schilder RJ and Ozols RF (1992) New therapies for ovarian cancer. Cancer Invest 10: 307-315
32. Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR and Karin M (1992) Oncoprotein-mediated signalling cascade stimulates C-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol 12: 3507-3513